Background: With the advent of endovenous truncal ablation under local anaesthetic for the treatment of varicose veins, the fate of varicosed tributaries has become controversial, with centres offering different timings of treatment, if offered at all. This study aims to review the literature assessing delayed and simultaneous varicosity treatment during truncal ablation. Methods: Randomised trials and cohort studies concerning varicosity treatment timing were identified through a systematic literature search. Requirements for further treatment, quality of life and rate of venous thrombotic events were assessed for meta-analysis. Results: Four studies were identified assessing need for further varicosity procedure, with no significant difference seen between simultaneous or delayed treatment (p ¼ 0.339). Two studies assessed quality of life, with simultaneous treatment providing significantly improved outcomes at six weeks (p ¼ 0.029) but not at 12 weeks (p ¼ 0.283). Studies examining venous thrombotic events showed no difference in venous thromboembolism rate between simultaneous or delayed treatment approaches (p ¼ 0.078).
Introduction
The traditional treatment of great saphenous vein (GSV) varicose veins has comprised of saphenofemoral junction ligation and stripping of the GSV under general anaesthesia. At this point, phlebectomies or multiple stab avulsions were performed to remove the visible varicosities. This enabled complete treatment of the pathological venous system in one sitting and became the standard of care.
Local anaesthesia and patient choice
With the advent of minimally invasive endovenous procedures, treatment pathways have changed with patient comfort and experience coming to the fore. phlebectomy treatment, and historically these were felt to be too painful for local anaesthetic management. With the emergence of tumescent local anaesthesia, this consensus has changed with endovenous thermal ablation procedures commonly performed without the need for general anaesthesia or sedation. Moreover, a number of authors have described the feasibility and patient acceptance of phlebectomies performed using local anaesthetic, either alone or in combination with endovenous truncal ablation. 7, 8 Additionally, studies have shown the safety of foam sclerotherapy during endovenous ablation. 9 Previous work has assessed patient preference for inguinal hernia repair, showing 47% of patients opting for general anaesthetic, compared to 33% for local. 10 Conversely, in the context of varicose veins, patients preferred local anaesthesia (71%) and singlesession treatment (63%). 2 
Reflux/varicosities
The clinician therefore has a choice -to treat the varicosities in a single sitting with the truncal vein treatment or to plan treatment over two (or more) sessions to address both the truncal incompetence and varicosity treatment separately. Additionally, one can opt for treatment of solely the varicosities or the truncal vein. Consequently, the treatment of visible varicosities after great or SSV surgery has been the subject of considerable debate. 11, 12 Following ablation of the incompetent truncal vein, the varicosities should, according to the descending haemodynamic theory, shrink down and become asymptomatic due to reduced flow. 13 However, persistence of varicosities may occur despite technically successful truncal vein ablation.
14 Additionally, recent evidence has shown that even techniques with robust occlusion and success rates can incur early recurrence, 15, 16 affecting long-term treatment needs. This systematic review and meta-analysis aims to summarise the published literature regarding the timing of adjunctive procedures for the treatment of varicosities in patients undergoing truncal vein ablation.
Methods

Search strategy
A search of the published literature was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 17 Literature searches were performed by two authors (TL and SO). The PubMed and EMBASE online databases were searched to July 2013 using the OVID online portal. In cases of dispute, a third reviewer was asked to independently assess the article (AHD). 
Search criteria
Inclusion criteria were
. Studies assessing the timing and outcome of phlebectomies in the context of ablation of the GSV or SSV for the treatment of varicose veins.
Exclusion criteria were:
. 
Results
Search outcomes
Search outcomes are shown in Figure 1 . Few studies investigated the principle study question of varicosity treatment timing, excluding many well-conducted trials. The studies included are described in Table 1 , with risk of bias assessment displayed in Figure 2 .
Three clinical questions were identified from the literature search -the need for further procedures, quality of life (QOL) outcomes and rate of deep venous thrombosis (DVT).
Need for further procedure
Only four studies reported outcomes for groups stratified for timing of phlebectomy. Two studies were formal randomised controlled trials investigating concomitant and delayed treatment of varicosities with either phlebectomy (n ¼ 50) 20 or foam sclerotherapy (n ¼ 68) 21 after GSV endovenous laser ablation (EVLA). Two studies were retrospective cohort studies assessing the need for secondary interventions after endovenous thermal ablation with either radiofrequency (n ¼ 184) 22 or laser (n ¼ 265). 23 However, whilst Welch's 2006 study 22 included both groups, the study was excluded as only seven of 184 patients underwent truncal ablation with simultaneous treatment of varicosities. Kim et al. 23 described a large study with even groups of 132 patients (simultaneous) and 133 patients (delayed) with 12 and 11 patients requiring further treatment respectively. Carradice et al. 20 performed the only randomised clinical trial (RCT) assessing the timing of varicosity treatment in the context of endovenous ablation. In this study, 16/25 (64%) of patients required further treatment for varicosities after truncal ablation alone, compared to one of 25 (4%) in the group treated with concomitant phlebectomy. The study by Theivacumar et al. 24 was an RCT assessing the outcomes of differing treatment protocols for the below knee GSV in the context of EVLA. A total of 46 patients received EVLA alone, with 18 (39%) requiring further treatment, compared to 22 patients receiving EVLA and ultrasound-guided foam sclerotherapy (UGFS) combined, with 8 (36%) requiring further treatment.
The subsequent forest plot of three studies assessing need for further procedure is demonstrated in Figure 3 . These figures show that there is no significant difference in need for further procedures (odds ratio 0.734, p ¼ 0.339, ratio >1 favouring delayed group), although the statistical heterogeneity (I 2 ) is high at 81%. Isolating the RCTs produces a more clinically homogenous group, but I 2 increases to 88%, with a non-significant trend towards reduced need for further procedure in the simultaneous group (odds ratio 0.443, p ¼ 0.092). 
QOL outcomes
Both randomised trials assessed QOL at six and 12 weeks post treatment. The forest plot showing QOL outcomes at six weeks is presented in Figure 6 . Carradice et al. reported greatly improved Aberdeen Varicose Vein Questionnaire scores (AVVQ) at six weeks in the simultaneous group compared to Theivacumar et al. This may be secondary to the differences in number of patients requiring further treatment.
Pooling of the data shows a significant improvement in AVVQ at six weeks for the simultaneous group (odds ratio of 0.460, p ¼ 0.029) (Figure 4 ).
There were no significant differences in QOL changes between groups by 12 weeks (odds ratio 0.688, p ¼ 0.283) ( Figure 5 ).
Incidence of DVT or endovenous heat-induced thrombosis
Three studies have examined the role of combined phlebectomy and venous ablation on the incidence of venous thromboembolism (VTE). All are retrospective analyses of prospectively gathered data during changing practice from operating theatre to procedure room, and from general anaesthetic (GA) to local anaesthetic (LA). [25] [26] [27] These studies describe routine post-operative duplex ultrasound follow-up assessing technical success of treatment (occlusion rates) and complications (DVT). DVT incidence rates describe those associated with the initial treatment session.
The first study of 293 limbs by Puggioni et al. 25 showed a significantly increased occurrence of thrombotic events in the cohort treated with combined phlebectomy and radiofrequency ablation (RFA) 28 with extension into but not occlusion of the common femoral vein at the saphenofemoral junction. However, the combined phlebectomy group procedures were all performed under general anaesthetic, with the procedures where phlebectomy was deferred all performed under local anaesthetic. Neither groups received pharmaceutical DVT prophylaxis. The study also does not report on the number of additional procedures required after the initial treatment. Post-operative duplex ultrasound scans were completed at a mean of 5.8 days ( AE 1.8 days) and 53.5 days ( AE 66 days). Timing of DVT or EHIT event detection is unclear in this study.
Other studies have reported a much lower incidence of DVT after endovenous ablation, 29, 30 including the second study by Knipp et al. 27 which examined DVT in the context of combined and non-combined procedures.
This study included 456 limbs, with an overall DVT incidence of 0.7% (3/456) and an EHIT incidence of 7% (32/456). A total of 181 procedures were completed under GA, 107 with pharmaceutical DVT prophylaxis and 74 without. There were four treatment failures, which were not analysed. Three hundred twenty-one limbs were treated with EVLA alone, and 135 had combined EVLA and phlebectomy. DVT and EHIT rates were not significantly different between GA and LA or between prophylaxis groups. When assessing the combined EVLA and phlebectomy group with the EVLA solely groups, it was found that rates of DVT were higher in patients undergoing concomitant phlebectomy (2.2% versus 0%, p ¼ 0.028), but EHIT rates remained unchanged (5.9% versus 7.8%, p ¼ 0.554). This gave a DVT or EHIT rate of 12/135 in the concomitant group and 23/321 in the delayed group. Postoperative duplex ultrasound scans were performed at one month, three months, six months and 12 months; however, the timing of DVT or EHIT events is not described.
Finally, Marsh et al. 26 retrospectively assessed 2820 endovenous procedures, 2470 RFA under GA with concomitant phlebectomies and 350 EVLA under LA with delayed phlebectomies. All patients received pharmacological DVT prophylaxis. An overall DVT or EHIT rate of 0.7% was described (21/2820), with 17 post RFA (0.7%) and four post EVLA (1.1%). There was no significant difference between treatment groups. However, in 567 RFA procedures, short saphenous ligation was performed in addition to RFA and phlebectomies. These cases accounted for seven of 21 of thromboses. Excluding these cases, the comparison would be seven of 1903 (0.37%) compared to four of 350 (1.14%). In this study, all EHITs were categories 2-4, 28 classifying them as DVT. All post-operative scans were completed at two weeks. Overall, the rate of any thrombotic event was extremely low throughout. These studies are pooled in Figure 6 .
This indicates no significant difference in risks of DVT or EHIT between simultaneous and delayed treatment pathways (odds ratio ¼ 1.519, p ¼ 0.078). Statistical heterogeneity is 80%, and indeed clinical heterogeneity between groups (but not studies) is also high, with combined procedures under GA and endovenous interventions only under LA. Fernandez et al. 31 found a DVT rate of 0.13% after 1985 combined EVLA and phlebectomy procedures under LA, compared to the above studies range of 0.7%-22% under GA.
The three studies assessing need for further procedures post endovenous ablation identified no DVT's in either group (0/250), with Carradice et al. and Theivacumar et al. both performing treatment under local anaesthetic only and Kim et al. offering general anaesthetic, regional spinal anaesthetic or local anaesthetic. If these three studies are added into the metaanalysis, the resulting analysis is obtained (Figure 7) .
With the addition of these further cases, the statistical heterogeneity is reduced to 50% (p ¼ 0.076), but there remains no significant difference in rate of EHIT or DVT between simultaneous or delayed varicosity treatment (odds ratio ¼ 1.508, p ¼ 0.077, odds ratio >1 favours delayed treatment).
Discussion
This review of the literature has shown that despite extensive work assessing technical and patient-reported outcomes after endovenous treatments, studies investigating secondary interventions are scarce. The evidence that does exist, whilst including level 2 evidence 20, 21 only serves to fuel the controversy, with both simultaneous and delayed varicosity treatment pathways offering benefits. There is a non-significant trend towards simultaneous phlebectomies in the context of avoiding secondary procedures and early QOL improvements. However, firm conclusions cannot be drawn as the patient numbers are small and both treatment options seem to offer good and equivalent QOL and disease improvement at one year. The technique described in the study by Theivacumar et al. is catheter-directed foam sclerotherapy to the distal GSV rather than direct varicosity treatment (with either phlebectomy or sclerotherapy). This may limit the applicability of its results in comparing delayed and simultaneous varicosity treatment. However, due to the dispersing nature of foam sclerotherapy and the average length of vein treated (19 cm), tributaries of the treated vein will have received foam sclerotherapy treatment, as has been shown in other studies. 32 Additional treatments were either repeat injection via catheter or direct injection. 21 Interestingly, this review identified two large retrospective single-centre studies showing that combined phlebectomy and ablation and delayed treatment pathways had similar risks of DVT or EHIT. 26, 27 The third study identified suggested that the DVT risk may be greater in patients treated with concomitant phlebectomy, although the lack of thromboprophylaxis may also have influenced the DVT rates in this study. 25 Crucially, these studies investigating the rate of VTE have not clearly described the risk of VTE after the delayed varicosity treatment, or the number of patients requiring further interventions. A retrospective study of the National Health Service Hospital Episode Statistics database 33 found an increased risk of all cause VTE within 12 months after GA combined ablation and phlebectomy (1.26 versus 0.47, p ¼ 0.01), compared to ablation alone, with a 0/360 episodes of VTE found in LA cases. Phlebectomy was not described alone, but combined sclerotherapy and phlebectomy showed a 0% rate of VTE (in only 71 procedures). No duplex ultrasound data or causation was available in this study, and so these must be used to identify general trends only.
Modern day practice facilitates venous procedures being performed under LA with excellent results reported in randomised trials. [34] [35] [36] These trials include phlebectomies or foam sclerotherapy of varicosities. Sutton et al. 33 found a 0% rate of VTE after LA procedures in their HES database report. With tumescent anaesthesia now in widespread use, 5 it is clear that multiple extensive venous procedures are feasible and well tolerated without the need for general anaesthesia or sedation.
Overall, delayed phlebectomy treatment offers a non-significant trend towards reduced VTE at the expense of significantly reduced early QOL outcomes and a non-significant trend for more further procedures.
The recent NICE guidelines for the management of varicose veins 37, 38 recognised the lack of high-quality evidence evaluating the treatment of varicosities and recommended this topic as a research priority, whilst also recommending that clinicians should consider offering patients simultaneous treatment of varicosities along with truncal ablation.
This review of the literature and summary of outcomes is limited by the paucity of studies assessing a crucial component of varicose vein treatment. The randomised studies available offer some guidance but only cover 118 procedures. Many studies were identified that assessed various treatment methods for truncal veins; however, very few assessed the need for phlebectomies.
The larger non-randomised retrospective studies are limited by their methodology but offer a large sample size. These studies have a major confounding factor, as procedures changed from GA to LA during the study period. This may have affected the outcomes, and so the analyses should be interpreted with caution. However, with such low rates of thrombotic events found, the need for large registry style data is required to investigate the clinical question in the era of full tumescent anaesthesia.
No formal assessment of cost-effectiveness has been completed to date, though one randomised study did find that combined treatment took over 33% longer to complete (65 min versus 45 min, p ¼ 0.002). 20 With modernisation and refinement of equipment, techniques and 39 ) may provide further evidence to guide clinicians in the future.
With the advent of venous registries 40, 41 and many centres moving to predominantly local anaesthetic procedures, large patient series assessing the role of phlebectomies in the modern era may also play a role, with outcomes ideally including QOL, need for further procedures and complications key to improvements.
Patient preference must also be taken into account. Many patients prefer one-stop treatment, a trend that has persisted for over a decade. 2, 42 This limits the generalisability of sequenced treatment trial data due to patients opting out.
Conclusion
There is at present no conclusive evidence for or against combined venous ablation and varicosity treatment; however, the limited data does show some trends. Therefore, clinician judgement in combination with clinician and patient preference is the key to formulating satisfactory venous treatment pathways, pending the results of further RCT data.
